Nephrology
- Extraosseous calcification in kidney disease
The following article in the February 2022 issue contained an error: Bartolomeo K, Tan XY, Fatica R. Extraosseous calcification in kidney disease. Cleve Clin J Med 2022; 89(2):81–90. doi:10.3949/ccjm.89a.21073
- Extraosseous calcification in kidney disease
A review of the pathogenesis, presentation, diagnosis, and treatment of vascular and soft tissue calcifi cation.
- SGLT-2 inhibitors are potential game-changers (for more than diabetes)
Data from large clinical trials and improved understanding of the biologic effects of these drugs are changing expectations for the clinical course in patients with diabetes, as well as chronic kidney disease and heart failure.
- SGLT-2 inhibitors in heart failure: Time for broader eligibility and earlier initiation
SGLT-2 inhibitors remain vastly underused in clinical practice despite their broad cardiorenal benefits.
- Can I place a peripherally inserted central catheter in my patient with chronic kidney disease?
Future need for permanent dialysis access is an important consideration.
- How do you effectively evaluate the elderly for alcohol use disorder?
A brief review of clues to an underrecognized and underdiagnosed problem with physical as well as emotional and social consequences.
- The obesity paradox in heart failure: What is the role of cardiorespiratory fitness?
What should these patients be advised about weight management and about cardiorespiratory fitness, a major factor influencing the paradox?
- Promoting physical activity in older women to maximize health
The optimal type, intensity, and level required to achieve specific health outcomes depend on the disease the patient and clinician are trying to prevent or manage.
- Medical complications of bulimia nervosa
Complications can affect all body systems, but especially the renal and electrolyte systems.